Cationic Colloidal Carriers for Delivery of Active Agents to the Blood-Brain Barrier in the Course of Neuroinflammatory Diseases
Abstract
The present invention relates to the use of cationic colloidal compositions for the targeted delivery of an active compound to an inflammatory site or an activated vascular site for the preparation of a medicament for the treatment of MS and in general for all CNS or PNS inflammatory neurodegenerative and demyelinating diseases and for diagnostic applications of such compositions
Classe Tecnologica
A - Human Necessities
Patent Office
United States Patent and Trademark Office
Numero Deposito
US2011002851
Anno Deposito
2007
Anno Concessione
2011
Inventori Pugliesi
- Riccio Paolo
Tutti gli inventori
- Heinrich Haas
- Paolo Riccio
Titolari pugliesi
- Non ci sono titolari pugliesi
Tutti i titolari
- MediGene AG
Condividi questo sito sui social